Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
New York: John Wiley & Sons
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis
Studies Show GLP-1 Weight-Loss Drugs Leading to Loss of Critical Lean Mass News provided by BodySpec Oct 02, 2023, 10:10 ET Body Composition Changes Must Be Closely Monitored While Taking These Drugs, Not Just the Number on the Scale
Available from: Dong L, Umehara H, Zhong J
Give the full four weeks before evaluating effectiveness
This research was funded by the Polish National Science Center, NCN 2021/43/D/NZ3/00428
US$ 26.25
US$ 23.24
US$ 29.03
US$ 26.03
US$ 27.75
US$ 22.97
